ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,334, issued on Aug. 4, was assigned to SANOFI BIOTECHNOLOGY (Gentilly, France).
"Anti-IL-1R3 antibodies for use in inflammatory conditions" was invented by Stephan Fischer (Weilheim, Germany) and Karsten Beckmann (Vaterstetten, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for treating medical conditions and/or disorders characterized by uncontrolled or abnormal expression of members of the IL1R3 signaling pathway such as IL-1Alpha, IL-1B, IL-33, IL-36, IL1RA and/or IL1R3, as well as variants thereof.More specifically, the present invention relates to anti-IL1R3 antibodies for use in the treatment of ...